has role has attribute value has attribute bromfenac 2-amino-3-(4-bromobenzoyl)benzeneacetic acid Amfenac in which the the hydrogen at the 4 position of the benzoyl group is substituted by bromine. It is used for the management of ocular pain and treatment of postoperative inflammation in patients who have undergone cataract extraction. It was withdrawn from the US market in 1998, following concerns over off-label abuse and hepatic failure. Beilstein:8335547 CAS:91714-94-2 CHEBI:240107 DrugBank:DB00963 Drug_Central:401 LINCS:LSM-5585 [2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid [2-amino-3-(4-bromobenzoyl)phenyl]acetic acid bromfenac bromfenaco bromfenacum non-steroidal anti-inflammatory drug non-narcotic analgesic organic molecular entity drug liver toxicity Most-DILI-Concern